clenbuterol has been researched along with Hyperplasia in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denda, M | 1 |
| Fuziwara, S | 1 |
| Inoue, K | 1 |
| Illera, JC | 1 |
| Silván, G | 1 |
| Blass, A | 1 |
| Martínez, MM | 1 |
| Illera, M | 1 |
2 other studies available for clenbuterol and Hyperplasia
| Article | Year |
|---|---|
Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alpre | 2003 |
The effect of clenbuterol on adrenal function in rats.
Topics: Adrenal Glands; Adrenergic beta-Agonists; Anabolic Agents; Animals; Body Weight; Clenbuterol; Female | 1998 |